Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (148)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Nestorowicz, A.
Right arrow Articles by Permutt, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nestorowicz, A.
Right arrow Articles by Permutt, M. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 5, 1813-1822, Copyright © 1996 by Oxford University Press


ARTICLES

Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews

A Nestorowicz, BA Wilson, KP Schoor, H Inoue, B Glaser, H Landau, CA Stanley, PS Thornton, JP Clement 4th, J Bryan, L Aguilar-Bryan and MA Permutt
Division of Endocrinology, Diabetes and Metabolism, Washington University School of Medicine, St Louis, MO 63110, USA.

Familial hyperinsulinism (HI) is a disorder of pancreatic beta-cell function characterized by persistent hyperinsulinism despite severe hypoglycemia. To define the molecular genetic basis of HI in Ashkenazi Jews, 25 probands were screened for mutations in the sulfonylurea receptor (SUR1) gene by single-strand conformation polymorphism (SSCP) analysis of genomic DNA and subsequent nucleotide sequence analyses. Two common mutations were identified: (I) a novel in-frame deletion of three nucleotides (nt) in exon 34, resulting in deletion of the codon for F1388 (delta F1388) and (II) a previously described g-->a transition at position-9 of the 3' splice site of intron 32 (designated 3992-9g-->a). Together, these mutations are associated with 88% of the HI chromosomes of the patients studied. 86Rb+ efflux measurements of COSm6 cells co-expressing Kir6.2 and either wild-type or delta F1388 SUR1 revealed that the F1388 mutation abolished ATP-sensitive potassium channel (KATP) activity in intact cells. Extended haplotype analyses indicated that the delta F1388 mutation was associated with a single specific haplotype whereas the 3992-9g-->a mutation was primarily associated with a single haplotype but also occurred in the context of several other different haplotypes. These data suggest that HI in Ashkenazi Jews is predominantly associated with mutations in the SUR1 gene and provide evidence for the existence of at least two founder HI chromosomes in this population.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
K Mazor-Aronovitch, D Gillis, D Lobel, H J Hirsch, O Pinhas-Hamiel, D Modan-Moses, B Glaser, and H Landau
Long-term neurodevelopmental outcome in conservatively treated congenital hyperinsulinism
Eur. J. Endocrinol., October 1, 2007; 157(4): 491 - 497.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Suzuki, Y. Makita, T. Mukai, K. Matsuo, O. Ueda, and K. Fujieda
Molecular Basis of Neonatal Diabetes in Japanese Patients
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3979 - 3985.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
V. Valayannopoulos, M. Vaxillaire, Y. Aigrain, F. Jaubert, C. Bellanne-Chantelot, M.-J. Ribeiro, F. Brunelle, P. Froguel, J.-J. Robert, M. Polak, et al.
Coexistence in the Same Family of Both Focal and Diffuse Forms of Hyperinsulinism
Diabetes Care, June 1, 2007; 30(6): 1590 - 1592.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Giurgea, C. Sempoux, C. Bellanne-Chantelot, M. Ribeiro, L. Hubert, N. Boddaert, J.-M. Saudubray, J.-J. Robert, F. Brunelle, J. Rahier, et al.
The Knudson's Two-Hit Model and Timing of Somatic Mutation May Account for the Phenotypic Diversity of Focal Congenital Hyperinsulinism
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4118 - 4123.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Hussain, M. Seppanen, K. Nanto-Salonen, N. S. Adzick, C. A. Stanley, P. Thornton, and H. Minn
The Diagnosis of Ectopic Focal Hyperinsulinism of Infancy with [18F]-Dopa Positron Emission Tomography
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2839 - 2842.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
I Giurgea, D Sanlaville, J-C Fournet, C Sempoux, C Bellanne-Chantelot, G Touati, L Hubert, M-S Groos, F Brunelle, J Rahier, et al.
Congenital hyperinsulinism and mosaic abnormalities of the ploidy
J. Med. Genet., March 1, 2006; 43(3): 248 - 254.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-W. Lin, C. MacMullen, A. Ganguly, C. A. Stanley, and S.-L. Shyng
A Novel KCNJ11 Mutation Associated with Congenital Hyperinsulinism Reduces the Intrinsic Open Probability of beta-Cell ATP-sensitive Potassium Channels
J. Biol. Chem., February 3, 2006; 281(5): 3006 - 3012.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Hussain, J. Bryan, H. T. Christesen, K. Brusgaard, and L. Aguilar-Bryan
Serum Glucagon Counterregulatory Hormonal Response to Hypoglycemia Is Blunted in Congenital Hyperinsulinism
Diabetes, October 1, 2005; 54(10): 2946 - 2951.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
I. Giurgea, T. Ulinski, G. Touati, C. Sempoux, F. Mochel, F. Brunelle, J.-M. Saudubray, C. Fekete, and P. de Lonlay
Factitious Hyperinsulinism Leading to Pancreatectomy: Severe Forms of Munchausen Syndrome by Proxy
Pediatrics, July 1, 2005; 116(1): e145 - e148.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M.-J. Ribeiro, P. De Lonlay, T. Delzescaux, N. Boddaert, F. Jaubert, S. Bourgeois, F. Dolle, C. Nihoul-Fekete, A. Syrota, and F. Brunelle
Characterization of Hyperinsulinism in Infancy Assessed with PET and 18F-Fluoro-L-DOPA
J. Nucl. Med., April 1, 2005; 46(4): 560 - 566.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Seebohm
Activators of Cation Channels: Potential in Treatment of Channelopathies
Mol. Pharmacol., March 1, 2005; 67(3): 585 - 588.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. J. Henwood, A. Kelly, C. MacMullen, P. Bhatia, A. Ganguly, P. S. Thornton, and C. A. Stanley
Genotype-Phenotype Correlations in Children with Congenital Hyperinsulinism Due to Recessive Mutations of the Adenosine Triphosphate-Sensitive Potassium Channel Genes
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 789 - 794.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Tornovsky, A. Crane, K. E. Cosgrove, K. Hussain, J. Lavie, M. Heyman, Y. Nesher, N. Kuchinski, E. Ben-Shushan, O. Shatz, et al.
Hyperinsulinism of Infancy: Novel ABCC8 and KCNJ11 Mutations and Evidence for Additional Locus Heterogeneity
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6224 - 6234.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. N. Magge, S.-L. Shyng, C. MacMullen, L. Steinkrauss, A. Ganguly, L. E. L. Katz, and C. A. Stanley
Familial Leucine-Sensitive Hypoglycemia of Infancy Due to a Dominant Mutation of the {beta}-Cell Sulfonylurea Receptor
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4450 - 4456.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Crane and L. Aguilar-Bryan
Assembly, Maturation, and Turnover of KATP Channel Subunits
J. Biol. Chem., March 5, 2004; 279(10): 9080 - 9090.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Giurgea, K. Laborde, G. Touati, C. Bellanne-Chantelot, M.-C. Nassogne, C. Sempoux, F. Jaubert, N. Khoa, V. Chigot, J. Rahier, et al.
Acute Insulin Responses to Calcium and Tolbutamide Do Not Differentiate Focal from Diffuse Congenital Hyperinsulinism
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 925 - 929.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. A. Stanley, P. S. Thornton, A. Ganguly, C. MacMullen, P. Underwood, P. Bhatia, L. Steinkrauss, L. Wanner, R. Kaye, E. Ruchelli, et al.
Preoperative Evaluation of Infants with Focal or Diffuse Congenital Hyperinsulinism by Intravenous Acute Insulin Response Tests and Selective Pancreatic Arterial Calcium Stimulation
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 288 - 296.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. J. DUNNE, K. E. COSGROVE, R. M. SHEPHERD, A. AYNSLEY-GREEN, and K. J. LINDLEY
Hyperinsulinism in Infancy: From Basic Science to Clinical Disease
Physiol Rev, January 1, 2004; 84(1): 239 - 275.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. S. Thornton, C. MacMullen, A. Ganguly, E. Ruchelli, L. Steinkrauss, A. Crane, L. Aguilar-Bryan, and C. A. Stanley
Clinical and Molecular Characterization of a Dominant Form of Congenital Hyperinsulinism Caused by a Mutation in the High-Affinity Sulfonylurea Receptor
Diabetes, September 1, 2003; 52(9): 2403 - 2410.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. A. Stanley
Advances in Diagnosis and Treatment of Hyperinsulinism in Infants and Children
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4857 - 4859.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Huopio, J. Jaaskelainen, J. Komulainen, R. Miettinen, P. Karkkainen, M. Laakso, P. Tapanainen, R. Voutilainen, and T. Otonkoski
Acute Insulin Response Tests for the Differential Diagnosis of Congenital Hyperinsulinism
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4502 - 4507.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Huopio, S.-L. Shyng, T. Otonkoski, and C. G. Nichols
KATP channels and insulin secretion disorders
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E207 - E216.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Wang, B. R. Gauthier, K. A. Hagenfeldt-Johansson, M. Iezzi, and C. B. Wollheim
Foxa2 (HNF3beta ) Controls Multiple Genes Implicated in Metabolism-Secretion Coupling of Glucose-induced Insulin Release
J. Biol. Chem., May 10, 2002; 277(20): 17564 - 17570.
[Abstract] [Full Text] [PDF]


Home page
CLIN PEDIATRHome page
B. Dekel, D. Lubin, D. Modan-Moses, J. Quint, B. Glaser, and J. Meyerovitch
Compound Heterozygosity for the Common Sulfonylurea Receptor Mutations Can Cause Mild Diazoxide-Sensitive Hyperinsulinism
Clinical Pediatrics, April 1, 2002; 41(3): 183 - 186.
[Abstract] [PDF]


Home page
DiabetesHome page
H. B.T. Christesen, B. B. Jacobsen, S. Odili, C. Buettger, A. Cuesta-Munoz, T. Hansen, K. Brusgaard, O. Massa, M. A. Magnuson, C. Shiota, et al.
The Second Activating Glucokinase Mutation (A456V): Implications for Glucose Homeostasis and Diabetes Therapy
Diabetes, April 1, 2002; 51(4): 1240 - 1246.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. A. Kassem, I. Ariel, P. S. Thornton, K. Hussain, V. Smith, K. J. Lindley, A. Aynsley-Green, and B. Glaser
p57KIP2 Expression in Normal Islet Cells and in Hyperinsulinism of Infancy
Diabetes, December 1, 2001; 50(12): 2763 - 2769.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
N. J. Sund, M. Z. Vatamaniuk, M. Casey, S.-L. Ang, M. A. Magnuson, D. A. Stoffers, F. M. Matschinsky, and K. H. Kaestner
Tissue-specific deletion of Foxa2 in pancreatic {beta} cells results in hyperinsulinemic hypoglycemia
Genes & Dev., July 1, 2001; 15(13): 1706 - 1715.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J.-C. Fournet, C. Mayaud, P. de Lonlay, M.-S. Gross-Morand, V. Verkarre, M. Castanet, M. Devillers, J. Rahier, F. Brunelle, J.-J. Robert, et al.
Unbalanced Expression of 11p15 Imprinted Genes in Focal Forms of Congenital Hyperinsulinism : Association with a Reduction to Homozygosity of a Mutation in ABCC8 or KCNJ11
Am. J. Pathol., June 1, 2001; 158(6): 2177 - 2184.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. MacMullen, J. Fang, B. Y. L. Hsu, A. Kelly, P. de Lonlay-Debeney, J.-M. Saudubray, A. Ganguly, T. J. Smith, and C. A. Stanley
Hyperinsulinism/Hyperammonemia Syndrome in Children with Regulatory Mutations in the Inhibitory Guanosine Triphosphate-Binding Domain of Glutamate Dehydrogenase
J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1782 - 1787.
[Abstract] [Full Text]


Home page
DiabetesHome page
M. A. Permutt, J. C. Wasson, B. K. Suarez, J. Lin, J. Thomas, J. Meyer, S. Lewitzky, J. S. Rennich, A. Parker, L. DuPrat, et al.
A Genome Scan for Type 2 Diabetes Susceptibility Loci in a Genetically Isolated Population
Diabetes, March 1, 2001; 50(3): 681 - 685.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. A. Cartier, L. R. Conti, C. A. Vandenberg, and S.-L. Shyng
Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy
PNAS, February 27, 2001; 98(5): 2882 - 2887.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Grimberg, R.J. Ferry Jr., A. Kelly, S. Koo-McCoy, K. Polonsky, B. Glaser, M.A. Permutt, L. Aguilar-Bryan, D. Stafford, P.S. Thornton, et al.
Dysregulation of Insulin Secretion in Children With Congenital Hyperinsulinism due to Sulfonylurea Receptor Mutations
Diabetes, February 1, 2001; 50(2): 322 - 328.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
C.-C. Shieh, M. Coghlan, J. P. Sullivan, and M. Gopalakrishnan
Potassium Channels: Molecular Defects, Diseases, and Therapeutic Opportunities
Pharmacol. Rev., December 1, 2000; 52(4): 557 - 594.
[Abstract] [Full Text] [PDF]


Home page
NeoReviewsHome page
P. M. Thomas
Neonatal Insulin Secretion and Persistent Hyperinsulinemia of Infancy
NeoReviews, November 1, 2000; 1(11): e210 - 214.
[Full Text]


Home page
Hum Mol GenetHome page
M. Nissim-Rafinia, O. Chiba-Falek, G. Sharon, A. Boss, and B. Kerem
Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations
Hum. Mol. Genet., July 22, 2000; 9(12): 1771 - 1778.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
B. Glaser, P. Thornton, T. Otonkoski, and C. Junien
Genetics of neonatal hyperinsulinism
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2000; 82(2): 79F - 86.
[Abstract] [Full Text]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
R. M Shepherd, K. E Cosgrove, R. E O'Brien, P. D Barnes, C. Ämmälä, and M. J Dunne
Hyperinsulinism of infancy: towards an understanding of unregulated insulin release
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2000; 82(2): 87F - 97.
[Abstract] [Full Text]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
J Rahier, Y Guiot, and C Sempoux
Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2000; 82(2): 108F - 112.
[Full Text]


Home page
FASEB J.Home page
M. R. ABRAHAM, A. JAHANGIR, A. E. ALEKSEEV, and A. TERZIC
Channelopathies of inwardly rectifying potassium channels
FASEB J, November 1, 1999; 13(14): 1901 - 1910.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
L. E. Levitt Katz, R. J. Ferry Jr., C. A. Stanley, P. F. Collett-Solberg, L. Baker, and P. Cohen
Suppression of Insulin Oversecretion by Subcutaneous Recombinant Human Insulin-Like Growth Factor I in Children with Congenital Hyperinsulinism Due to Defective {beta}-Cell Sulfonylurea Receptor
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3117 - 3124.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. Hernandez-Sanchez, Y. Ito, J. Ferrer, M. Reitman, and D. LeRoith
Characterization of the Mouse Sulfonylurea Receptor 1 Promoter and Its Regulation
J. Biol. Chem., June 25, 1999; 274(26): 18261 - 18270.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. de Lonlay-Debeney, F. Poggi-Travert, J.-C. Fournet, C. Sempoux, C. D. Vici, F. Brunelle, G. Touati, J. Rahier, C. Junien, C. Nihoul-Fekete, et al.
Clinical Features of 52 Neonates with Hyperinsulinism
N. Engl. J. Med., April 15, 1999; 340(15): 1169 - 1175.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. Aguilar-Bryan and J. Bryan
Molecular Biology of Adenosine Triphosphate-Sensitive Potassium Channels
Endocr. Rev., April 1, 1999; 20(2): 101 - 135.
[Abstract] [Full Text]


Home page
NEJMHome page
C. A. Stanley, Y. K. Lieu, B. Y.L. Hsu, A. B. Burlina, C. R. Greenberg, N. J. Hopwood, K. Perlman, B. H. Rich, E. Zammarchi, and M. Poncz
Hyperinsulinism and Hyperammonemia in Infants with Regulatory Mutations of the Glutamate Dehydrogenase Gene
N. Engl. J. Med., May 7, 1998; 338(19): 1352 - 1357.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
B. Glaser, P. Kesavan, M. Heyman, E. Davis, A. Cuesta, A. Buchs, C. A. Stanley, P. S. Thornton, M. A. Permutt, F. M. Matschinsky, et al.
Familial Hyperinsulinism Caused by an Activating Glucokinase Mutation
N. Engl. J. Med., January 22, 1998; 338(4): 226 - 230.
[Full Text] [PDF]


Home page
Genome ResHome page
M. J. Higgins, C. D. Day, N. J. Smilinich, L. Ni, P. R. Cooper, N. J. Nowak, C. Davies, P. J. de Jong, F. Hejtmancik, G. A. Evans, et al.
Contig Maps and Genomic Sequencing Identify Candidate Genes in the Usher 1C Locus
Genome Res., January 1, 1998; 8(1): 57 - 68.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Matsuo, S. Trapp, Y. Tanizawa, N. Kioka, T. Amachi, Y. Oka, F. M. Ashcroft, and K. Ueda
Functional Analysis of a Mutant Sulfonylurea Receptor, SUR1-R1420C, That Is Responsible for Persistent Hyperinsulinemic Hypoglycemia of Infancy
J. Biol. Chem., December 22, 2000; 275(52): 41184 - 41191.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. J. Partridge, D. J. Beech, and A. Sivaprasadarao
Identification and Pharmacological Correction of a Membrane Trafficking Defect Associated with a Mutation in the Sulfonylurea Receptor Causing Familial Hyperinsulinism
J. Biol. Chem., September 14, 2001; 276(38): 35947 - 35952.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.